Amgen's Prolia beats standard-of-care treatment in postmenopausal women with osteoporosis in post-market study
October 12 2015 - 8:00AM
Seeking Alpha
http://seekingalpha.com/news/2822816-amgens-prolia-beats-standard-of-care-treatment-in-postmenopausal-women-with-osteoporosis-in-post-market-study?source=partner_advfn&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
Merck (NYSE:MRK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Sep 2023 to Sep 2024
